VIKAS KUNDRA to Magnetic Resonance Imaging
This is a "connection" page, showing publications VIKAS KUNDRA has written about Magnetic Resonance Imaging.
Connection Strength
2.063
-
In vivo magnetic resonance imaging of orthotopic prostate cancer. Biotechniques. 2020 07; 69(1):395-403.
Score: 0.233
-
Magnetic Resonance Imaging and Bioluminescence Imaging for Evaluating Tumor Burden in Orthotopic Colon Cancer. Sci Rep. 2019 04 15; 9(1):6100.
Score: 0.216
-
Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis. AJR Am J Roentgenol. 2015 Apr; 204(4):W439-48.
Score: 0.163
-
Visualizing the prostate gland by MR imaging in young and old mice. PLoS One. 2013; 8(3):e55746.
Score: 0.142
-
Follow-up of known carcinoid liver metastases: is respiratory-gated t(2) fast spin-echo enough? Neuroendocrinology. 2011; 93(4):241-8.
Score: 0.124
-
Fast dixon-based multisequence and multiplanar MRI for whole-body detection of cancer metastases. J Magn Reson Imaging. 2009 May; 29(5):1154-62.
Score: 0.108
-
Signaling can be uncoupled from imaging of the somatostatin receptor type 2. Mol Imaging. 2007 Nov-Dec; 6(6):427-37.
Score: 0.098
-
Exogenous gene expression in tumors: noninvasive quantification with functional and anatomic imaging in a mouse model. Radiology. 2005 Jun; 235(3):950-8.
Score: 0.083
-
Hybrid magnetic resonance and PET imaging for prostate cancer recurrence. Curr Opin Oncol. 2023 05 01; 35(3):231-238.
Score: 0.071
-
Performance of O-RADS MRI Score for Classifying Indeterminate Adnexal Masses at US. Radiol Imaging Cancer. 2021 05; 3(3):e219008.
Score: 0.062
-
Multiparameter MRI and Clinical Factors for Predicting Early Response to Chemoradiotherapy in Cervical Cancer. Radiol Imaging Cancer. 2021 01; 3(1):e209038.
Score: 0.061
-
Advanced Imaging in Musculoskeletal Oncology: Moving Away From RECIST and Embracing Advanced Bone and Soft Tissue Tumor Imaging (ABASTI)-Part II-Novel Functional Imaging Techniques. Semin Ultrasound CT MR. 2021 Apr; 42(2):215-227.
Score: 0.059
-
Biopsy in Prostate Cancer. More Is Better. Radiol Imaging Cancer. 2020 07; 2(4):e204019.
Score: 0.059
-
Routes to Potentially Safer T1 Magnetic Resonance Imaging Contrast in a Compact Plasmonic Nanoparticle with Enhanced Fluorescence. ACS Nano. 2018 08 28; 12(8):8214-8223.
Score: 0.052
-
In Vivo Assessment of Ovarian Tumor Response to Tyrosine Kinase Inhibitor Pazopanib by Using Hyperpolarized 13C-Pyruvate MR Spectroscopy and 18F-FDG PET/CT Imaging in a Mouse Model. Radiology. 2017 12; 285(3):830-838.
Score: 0.048
-
Whole-body MRI in pediatric patients with cancer. Cancer Imaging. 2017 Feb 10; 17(1):6.
Score: 0.047
-
Tumor T1 Relaxation Time for Assessing Response to Bevacizumab Anti-Angiogenic Therapy in a Mouse Ovarian Cancer Model. PLoS One. 2015; 10(6):e0131095.
Score: 0.042
-
Imaging features of fibrolamellar hepatocellular carcinoma. AJR Am J Roentgenol. 2014 Mar; 202(3):544-52.
Score: 0.038
-
Conspicuity of bone metastases on fast Dixon-based multisequence whole-body MRI: clinical utility per sequence. Magn Reson Imaging. 2013 Jun; 31(5):669-75.
Score: 0.035
-
Carcinoid tumours: predicting the location of the primary neoplasm based on the sites of metastases. Eur Radiol. 2013 Feb; 23(2):400-7.
Score: 0.034
-
Reproducibility and comparison of DCE-MRI and DCE-CT perfusion parameters in a rat tumor model. Technol Cancer Res Treat. 2012 Jun; 11(3):279-88.
Score: 0.033
-
Fast Dixon whole-body MRI for detecting distant cancer metastasis: a preliminary clinical study. J Magn Reson Imaging. 2012 Feb; 35(2):399-408.
Score: 0.032
-
Fast three-dimensional dual echo dixon technique improves fat suppression in breast MRI. J Magn Reson Imaging. 2010 Apr; 31(4):889-94.
Score: 0.029
-
New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging. PLoS One. 2009 Oct 29; 4(10):e7628.
Score: 0.028
-
In vivo functional and anatomic imaging for assessment of in vivo gene transfer. Radiology. 2009 Sep; 252(3):763-71.
Score: 0.027
-
Feasibility of multiple-mouse dynamic contrast-enhanced MRI. Magn Reson Med. 2007 Sep; 58(3):610-5.
Score: 0.024
-
In vivo imaging of prostate cancer involving bone in a mouse model. Prostate. 2007 Jan 01; 67(1):50-60.
Score: 0.023
-
Prostate cancer imaging. Semin Roentgenol. 2006 Apr; 41(2):139-49.
Score: 0.022
-
Diagnostic Performance of Prostate-specific Antigen Density for Detecting Clinically Significant Prostate Cancer in the Era of Magnetic Resonance Imaging: A Systematic Review and Meta-analysis. Eur Urol Oncol. 2024 Apr; 7(2):189-203.
Score: 0.018
-
Advanced Imaging in Musculoskeletal Oncology: Moving Away From RECIST and Embracing Advanced Bone and Soft Tissue Tumor Imaging (ABASTI) - Part I - Tumor Response Criteria and Established Functional Imaging Techniques. Semin Ultrasound CT MR. 2021 Apr; 42(2):201-214.
Score: 0.015
-
Ocular extramedullary myeloid leukaemia. Br J Haematol. 2018 03; 180(5):738-740.
Score: 0.011
-
Renal cell carcinoma associated with Xp11.2 translocation/TFE gene fusion: imaging findings in 21 patients. Eur Radiol. 2017 Feb; 27(2):543-552.
Score: 0.011
-
Imaging long-term fate of intramyocardially implanted mesenchymal stem cells in a porcine myocardial infarction model. PLoS One. 2011; 6(9):e22949.
Score: 0.008
-
Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts. Neoplasia. 2007 Jun; 9(6):479-86.
Score: 0.006